Tags: Actavis | Allergan | Bloomberg | Buy

Actavis in Talks to Buy Allergan for at Least $60 Billion: Bloomberg

Wednesday, 12 Nov 2014 11:09 AM

Actavis Plc is in talks to buy Allergan Inc. for at least $60 billion in a deal that could culminate this month, Bloomberg reported, citing sources familiar with the matter.

The two companies are trying to narrow a gap of about $3 billion between what Actavis wants to pay and what Allergan is asking for, Bloomberg reported.

Allergan, which is trying to fend off a hostile takeover bid from Canadian drugmaker Valeant Pharmaceuticals International Inc, on Wednesday changed its bylaws associated with calling a special shareholder meeting.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Companies
Actavis Plc is in talks to buy Allergan Inc. for at least $60 billion in a deal that could culminate this month, Bloomberg reported, citing sources familiar with the matter.
Actavis, Allergan, Bloomberg, Buy
87
2014-09-12
Wednesday, 12 Nov 2014 11:09 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved